| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-02-24 21:15:02 UTC |
|---|
| Updated at | 2022-02-24 21:15:02 UTC |
|---|
| NP-MRD ID | NP0044757 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | 4beta-Hydroxywithanolide E |
|---|
| Description | 4Beta-hydroxywithanolide e belongs to the class of organic compounds known as withanolides and derivatives. These are c28 steroids structurally characterized by an ergostane skeleton usually functionalized at carbons 1, 22 and 26 to form a lactone ring. Thus, 4beta-hydroxywithanolide e is considered to be a sterol. 4beta-Hydroxywithanolide E is found in Physalis cinerascens, Physalis peruviana and Physalis viscosa. 4beta-Hydroxywithanolide E was first documented in 2014 (PMID: 24566854). Based on a literature review a significant number of articles have been published on 4beta-hydroxywithanolide e (PMID: 33633307) (PMID: 33338476) (PMID: 33200287) (PMID: 32159343) (PMID: 31402707) (PMID: 27920947). |
|---|
| Structure | [H][C@@]12C[C@]3([H])[C@]([H])(CC[C@@]4(C)[C@@]3(O)CC[C@@]4(O)[C@@](C)(O)[C@@]3([H])CC(C)=C(C)C(=O)O3)[C@@]3(C)C(=O)C=C[C@H](O)[C@@]13O2 InChI=1S/C28H38O8/c1-14-12-20(35-22(31)15(14)2)25(5,32)27(34)11-10-26(33)17-13-21-28(36-21)19(30)7-6-18(29)24(28,4)16(17)8-9-23(26,27)3/h6-7,16-17,19-21,30,32-34H,8-13H2,1-5H3/t16-,17+,19-,20+,21+,23-,24-,25-,26+,27-,28+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 4b-Hydroxywithanolide e | Generator | | 4Β-hydroxywithanolide e | Generator | | 4-Hydroxywithanolide e | MeSH |
|
|---|
| Chemical Formula | C28H38O8 |
|---|
| Average Mass | 502.6040 Da |
|---|
| Monoisotopic Mass | 502.25667 Da |
|---|
| IUPAC Name | (1S,2R,6S,7R,9R,11R,12R,15S,16S)-15-[(1S)-1-[(2R)-4,5-dimethyl-6-oxo-3,6-dihydro-2H-pyran-2-yl]-1-hydroxyethyl]-6,12,15-trihydroxy-2,16-dimethyl-8-oxapentacyclo[9.7.0.0^{2,7}.0^{7,9}.0^{12,16}]octadec-4-en-3-one |
|---|
| Traditional Name | (1S,2R,6S,7R,9R,11R,12R,15S,16S)-15-[(1S)-1-[(2R)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-1-hydroxyethyl]-6,12,15-trihydroxy-2,16-dimethyl-8-oxapentacyclo[9.7.0.0^{2,7}.0^{7,9}.0^{12,16}]octadec-4-en-3-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@]12C[C@]3([H])[C@]([H])(CC[C@@]4(C)[C@@]3(O)CC[C@@]4(O)[C@@](C)(O)[C@@]3([H])CC(C)=C(C)C(=O)O3)[C@@]3(C)C(=O)C=C[C@H](O)[C@@]13O2 |
|---|
| InChI Identifier | InChI=1S/C28H38O8/c1-14-12-20(35-22(31)15(14)2)25(5,32)27(34)11-10-26(33)17-13-21-28(36-21)19(30)7-6-18(29)24(28,4)16(17)8-9-23(26,27)3/h6-7,16-17,19-21,30,32-34H,8-13H2,1-5H3/t16-,17+,19-,20+,21+,23-,24-,25-,26+,27-,28+/m0/s1 |
|---|
| InChI Key | UPBUGICUKQIKTJ-KABTZXSUSA-N |
|---|
| Experimental Spectra |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 100 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 125 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 150 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 175 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 225 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 25 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 250 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as withanolides and derivatives. These are c28 steroids structurally characterized by an ergostane skeleton usually functionalized at carbons 1, 22 and 26 to form a lactone ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Steroid lactones |
|---|
| Direct Parent | Withanolides and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Withanolide-skeleton
- 5,6-epoxysteroid
- Dihydropyranone
- Oxepane
- Cyclohexenone
- Pyran
- Alpha,beta-unsaturated carboxylic ester
- Enoate ester
- Cyclic alcohol
- Tertiary alcohol
- Carboxylic acid ester
- Ketone
- Secondary alcohol
- Lactone
- Oxacycle
- Carboxylic acid derivative
- Organoheterocyclic compound
- Dialkyl ether
- Oxirane
- Ether
- Polyol
- Monocarboxylic acid or derivatives
- Carbonyl group
- Organic oxide
- Organic oxygen compound
- Hydrocarbon derivative
- Alcohol
- Organooxygen compound
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Hsieh KY, Tsai JY, Lin YH, Chang FR, Wang HC, Wu CC: Golden berry 4beta-hydroxywithanolide E prevents tumor necrosis factor alpha-induced procoagulant activity with enhanced cytotoxicity against human lung cancer cells. Sci Rep. 2021 Feb 25;11(1):4610. doi: 10.1038/s41598-021-84207-8. [PubMed:33633307 ]
- Xu WJ, Xiao Q, Lian CL, Zhang C, Liu JQ: The synthesis and cytotoxic activity of derivatives of 4beta-hydroxywithanolide E. Steroids. 2021 Feb;166:108776. doi: 10.1016/j.steroids.2020.108776. Epub 2020 Dec 15. [PubMed:33338476 ]
- Kumagai M, Yoshida I, Mishima T, Ide M, Fujita K, Doe M, Nishikawa K, Morimoto Y: 4beta-Hydroxywithanolide E and withanolide E from Physalis peruviana L. inhibit adipocyte differentiation of 3T3-L1 cells through modulation of mitotic clonal expansion. J Nat Med. 2021 Jan;75(1):232-239. doi: 10.1007/s11418-020-01458-x. Epub 2020 Nov 16. [PubMed:33200287 ]
- Yang WJ, Chen XM, Wang SQ, Hu HX, Cheng XP, Xu LT, Ren DM, Wang XN, Zhao BB, Lou HX, Shen T: 4beta-Hydroxywithanolide E from Goldenberry (Whole Fruits of Physalis peruviana L.) as a Promising Agent against Chronic Obstructive Pulmonary Disease. J Nat Prod. 2020 Apr 24;83(4):1217-1228. doi: 10.1021/acs.jnatprod.9b01265. Epub 2020 Mar 11. [PubMed:32159343 ]
- Le Canh VC, Le Ba V, Thi Hai Yen P, Le Thi L, Thi Thuy Hoai P, Huu Dat TT, Thao DT, Bach LG, Kim YH, Tuan Anh HL: Identification Of Potential Cytotoxic Inhibitors From Physalis Minima. Nat Prod Res. 2021 Jun;35(12):2082-2085. doi: 10.1080/14786419.2019.1650360. Epub 2019 Aug 12. [PubMed:31402707 ]
- Chang LC, Sang-Ngern M, Pezzuto JM, Ma C: The Daniel K. Inouye College of Pharmacy Scripts: Poha Berry (Physalis peruviana) with Potential Anti-inflammatory and Cancer Prevention Activities. Hawaii J Med Public Health. 2016 Nov;75(11):353-359. [PubMed:27920947 ]
- Ye ZN, Yuan F, Liu JQ, Peng XR, An T, Li X, Kong LM, Qiu MH, Li Y: Physalis peruviana-Derived 4beta-Hydroxywithanolide E, a Novel Antagonist of Wnt Signaling, Inhibits Colorectal Cancer In Vitro and In Vivo. Molecules. 2019 Mar 22;24(6). pii: molecules24061146. doi: 10.3390/molecules24061146. [PubMed:30909473 ]
- Wang HC, Hu HH, Chang FR, Tsai JY, Kuo CY, Wu YC, Wu CC: Different effects of 4beta-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells. Phytomedicine. 2019 Feb;53:213-222. doi: 10.1016/j.phymed.2018.09.017. Epub 2018 Sep 5. [PubMed:30668401 ]
- Park EJ, Sang-Ngern M, Chang LC, Pezzuto JM: Physalactone and 4beta-Hydroxywithanolide E Isolated from Physalis peruviana Inhibit LPS-Induced Expression of COX-2 and iNOS Accompanied by Abatement of Akt and STAT1. J Nat Prod. 2019 Mar 22;82(3):492-499. doi: 10.1021/acs.jnatprod.8b00861. Epub 2019 Jan 16. [PubMed:30649869 ]
- Ballesteros-Vivas D, Alvarez-Rivera G, Del Pilar Sanchez-Camargo A, Ibanez E, Parada-Alfonso F, Cifuentes A: A multi-analytical platform based on pressurized-liquid extraction, in vitro assays and liquid chromatography/gas chromatography coupled to high resolution mass spectrometry for food by-products valorisation. Part 1: Withanolides-rich fractions from goldenberry (Physalis peruviana L.) calyces obtained after extraction optimization as case study. J Chromatogr A. 2019 Jan 11;1584:155-164. doi: 10.1016/j.chroma.2018.11.055. Epub 2018 Nov 24. [PubMed:30553502 ]
- Tang JY, Huang HW, Wang HR, Chan YC, Haung JW, Shu CW, Wu YC, Chang HW: 4beta-Hydroxywithanolide E selectively induces oxidative DNA damage for selective killing of oral cancer cells. Environ Toxicol. 2018 Mar;33(3):295-304. doi: 10.1002/tox.22516. Epub 2017 Nov 22. [PubMed:29165875 ]
- Lee CC, Chang WH, Chang YS, Liu TY, Chen YC, Wu YC, Chang JG: 4beta-Hydroxywithanolide E Modulates Alternative Splicing of Apoptotic Genes in Human Hepatocellular Carcinoma Huh-7 Cells. Sci Rep. 2017 Aug 4;7(1):7290. doi: 10.1038/s41598-017-07472-6. [PubMed:28779122 ]
- Peng CY, You BJ, Lee CL, Wu YC, Lin WH, Lu TL, Chang FC, Lee HZ: The Roles of 4beta-Hydroxywithanolide E from Physalis peruviana on the Nrf2-Anti-Oxidant System and the Cell Cycle in Breast Cancer Cells. Am J Chin Med. 2016;44(3):617-36. doi: 10.1142/S0192415X16500348. Epub 2016 Apr 24. [PubMed:27109152 ]
- Park EJ, Sang-Ngern M, Chang LC, Pezzuto JM: Induction of cell cycle arrest and apoptosis with downregulation of Hsp90 client proteins and histone modification by 4beta-hydroxywithanolide E isolated from Physalis peruviana. Mol Nutr Food Res. 2016 Jun;60(6):1482-500. doi: 10.1002/mnfr.201500977. Epub 2016 May 11. [PubMed:27006100 ]
- Takimoto T, Kanbayashi Y, Toyoda T, Adachi Y, Furuta C, Suzuki K, Miwa T, Bannai M: 4beta-Hydroxywithanolide E isolated from Physalis pruinosa calyx decreases inflammatory responses by inhibiting the NF-kappaB signaling in diabetic mouse adipose tissue. Int J Obes (Lond). 2014 Nov;38(11):1432-9. doi: 10.1038/ijo.2014.33. Epub 2014 Feb 25. [PubMed:24566854 ]
- N. D. Abdullaev, E. A. Maslennikova, R. N. Tursunova, N. K. Abubakirov, M. R. Yagudaev. (1984). N. D. Abdullaev, E. A. Maslennikova, R. N. Tursunova, N. K. Abubakirov, M. R. Yagudaev. Withasteroids of Physalis. IV. 28-Hydrowithaphysanolide.13C NMR spectrum of 14-?-hydroxywithasteroids. Chemistry of Natural Compounds 1984, 20 (2) , 182-191. https://doi.org/10.1007/BF00579480. Chemistry of Natural Compounds.
|
|---|